Literature DB >> 33524511

Zuojin Pill ameliorates chronic atrophic gastritis induced by MNNG through TGF-β1/PI3K/Akt axis.

Yuling Tong1, Ruilin Wang2, Xia Liu2, Miao Tian2, Yanling Wang2, Yanfei Cui2, Wenjun Zou3, Yanling Zhao4.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Zuojin Pill (ZJP) is a classic prescription composed of Coptis chinensis and Tetradium ruticarpum (A.Juss.) T.G.Hartley, which is often used in the treatment of digestive system diseases. AIM OF THIS STUDY: The purpose of this study was to explore the therapeutic effect and potential mechanism of ZJP on chronic atrophic gastritis (CAG) induced by MNNG.
MATERIALS AND METHODS: The GES-1 and rat model of CAG was established by MNNG. Detection of cell viability, morphological changes and proliferation of GES-1 by CCK-8 and high content screening (HCS) assay. G-17, IL-8 and TNF-α in rat serum were detected by ELISA kit. The expression of related mRNA and protein on TGF-β1/PI3K/Akt signal axis were detected by RT-PCR and Western blot.
RESULTS: The results showed that ZJP could significantly improve the GES-1 damage induced by MNNG and improve the gastric histomorphology of CAG rats. The intervention of ZJP could significantly reduce the content of G-17 and inflammatory factors IL-8, TNF- α, IL-6 and IL-1β, inhibit the expression of TGF-β1, PI3K and their downstream signals p-Akt, p-mTOR, P70S6K, and promote the expression level of PTEN, LC3-II and Beclin-1.
CONCLUSION: ZJP has a good therapeutic effect on CAG induced by MNNG, which may be closely related to the inhibition of TGF-β1/PI3K/Akt signal pathway.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic atrophic gastritis; Coptis chinensis; MNNG; TGF-β1/PI3K/Akt; Tetradium ruticarpum; Zuojin pill

Year:  2021        PMID: 33524511     DOI: 10.1016/j.jep.2021.113893

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

1.  Clinical efficacy of Weisu granule combined with Weifuchun tablet in the treatment of chronic atrophic gastritis and its effect on serum G-17, PG I and PG II levels.

Authors:  Xiaolan Li; Minxiao Feng; Gang Yuan
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

2.  Huanglian Jiedu Decoction Exerts Antipyretic Effect by Inhibiting MAPK Signaling Pathway.

Authors:  Xing Li; Shizhang Wei; Xiao Ma; Haotian Li; Manyi Jing; Honghong Liu; Shengqi Niu; Yuling Tong; Lisheng Chen; Ying Wei; Sichen Ren; Yanling Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-31       Impact factor: 2.629

3.  Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pancreatic Cancer Treatment.

Authors:  Kunpeng Wang; Xiongying Miao; Fanhua Kong; Siqi Huang; Jinggang Mo; Chong Jin; Yanwen Zheng
Journal:  Drug Des Devel Ther       Date:  2021-09-04       Impact factor: 4.162

4.  Integrated serum pharmacochemistry and investigation of the anti-gastric ulcer effect of Zuojin pill in rats induced by ethanol.

Authors:  Jiaying Zhang; Yi Yin; Qianqian Xu; Xiaoqing Che; Chen Yu; Yan Ren; Dongsheng Li; Juanjuan Zhao
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

5.  Metabolomics Profiles Associated with the Treatment of Zuojin Pill on Patients with Chronic Nonatrophic Gastritis.

Authors:  Xiao Ma; Shuying Xie; Ruilin Wang; Zhongxia Wang; Manyi Jing; Haotian Li; Shizhang Wei; Honghong Liu; Jianyu Li; Qingyong He; Yanling Zhao
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

6.  Metabolomic Study of Zuojin Pill in Relieving 1-Methyl-3-nitro-1-nitrosoguanidine-Induced Chronic Atrophic Gastritis.

Authors:  Yuling Tong; Manyi Jing; Xu Zhao; Honghong Liu; Shizhang Wei; Ruisheng Li; Xia Liu; Min Wang; Hongtao Song; Yanling Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-17       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.